lactic acid has been researched along with n-bromoacetylethanolamine phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Ishiguro, M; Sakakibara, R; Shimokawa, R; Tominaga, N; Watanabe, M | 1 |
| Fukasawa, M; Hirata, T; Ijichi, K; Miura, S; Sakakibara, R; Watanabe, M | 1 |
2 other study(ies) available for lactic acid and n-bromoacetylethanolamine phosphate
| Article | Year |
|---|---|
Inhibition of fructose-6-phosphate,2-kinase by N-bromoacetylethanolamine phosphate in vitro and in vivo.
Topics: Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanolamines; Lactic Acid; Liver; Male; Mice; Mice, Inbred Strains; Perfusion; Phosphofructokinase-2; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Wistar; Recombinant Proteins; Testis; Triglycerides | 1997 |
Inhibition of tumor cell growth by a specific 6-phosphofructo-2-kinase inhibitor, N-bromoacetylethanolamine phosphate, and its analogues.
Topics: Animals; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Ethanolamines; Female; Humans; Lactic Acid; Mice; Neoplasms; Phosphofructokinase-2; Phosphotransferases (Alcohol Group Acceptor); Tumor Cells, Cultured | 2000 |